Skye Bioscience Management
Management criteria checks 2/4
Skye Bioscience's CEO is Punit Dhillon, appointed in Aug 2020, has a tenure of 3.83 years. total yearly compensation is $1.81M, comprised of 24.9% salary and 75.1% bonuses, including company stock and options. directly owns 0.1% of the company’s shares, worth $252.75K. The average tenure of the management team and the board of directors is 2.7 years and 2.7 years respectively.
Key information
Punit Dhillon
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 24.9% |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$37m |
| Dec 31 2023 | US$2m | US$450k | -US$38m |
| Sep 30 2023 | n/a | n/a | -US$43m |
| Jun 30 2023 | n/a | n/a | -US$21m |
| Mar 31 2023 | n/a | n/a | -US$22m |
| Dec 31 2022 | US$668k | US$433k | -US$19m |
| Sep 30 2022 | n/a | n/a | -US$12m |
| Jun 30 2022 | n/a | n/a | -US$11m |
| Mar 31 2022 | n/a | n/a | -US$9m |
| Dec 31 2021 | US$900k | US$400k | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$8m |
| Jun 30 2021 | n/a | n/a | -US$7m |
| Mar 31 2021 | n/a | n/a | -US$6m |
| Dec 31 2020 | US$615k | US$160k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$207k |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | US$13m |
| Dec 31 2019 | US$65k | n/a | US$1m |
| Sep 30 2019 | n/a | n/a | -US$10m |
| Jun 30 2019 | n/a | n/a | -US$7m |
| Mar 31 2019 | n/a | n/a | -US$26m |
| Dec 31 2018 | US$82k | n/a | -US$19m |
Compensation vs Market: Punit's total compensation ($USD1.81M) is about average for companies of similar size in the US market ($USD1.62M).
Compensation vs Earnings: Punit's compensation has increased whilst the company is unprofitable.
CEO
Punit Dhillon (44 yo)
3.8yrs
Tenure
US$1,807,338
Compensation
Mr. Punit S. Dhillon, BA, has been Chief Executive Officer of Skye Bioscience, Inc. since August 10, 2020. Mr. Dhillon serves as Chair of Skye Bioscience, Inc. He served as Principal Accounting Officer at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 3.8yrs | US$1.81m | 0.10% $ 252.8k | |
| Chief Financial Officer | 2.7yrs | US$1.27m | 0.0095% $ 23.8k | |
| Chief Scientific Officer | 1.5yrs | no data | no data | |
| Chief Development Officer | no data | no data | 0.0095% $ 23.8k |
2.7yrs
Average Tenure
43.5yo
Average Age
Experienced Management: SKYE's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 6.4yrs | US$1.81m | 0.10% $ 252.8k | |
| Director | less than a year | US$1.25m | 0% $ 0 | |
| Director | less than a year | US$74.08k | 0% $ 0 | |
| Independent Director | 2.9yrs | US$120.03k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$116.36k | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
| Independent Director | 2.5yrs | US$123.35k | 0% $ 0 | |
| Independent Director | 1.3yrs | US$102.28k | 0% $ 0 |
2.7yrs
Average Tenure
59yo
Average Age
Experienced Board: SKYE's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.